488 related articles for article (PubMed ID: 24058079)
1. Initial clinical experience with the GORE septal occluder for the treatment of atrial septal defects and patent foramen ovale.
Freixa X; Ibrahim R; Chan J; Garceau P; Dore A; Marcotte F; Mercier LA; Mongeon FP; Basmadjian A; Khairy P; Asgar AW
EuroIntervention; 2013 Sep; 9(5):629-35. PubMed ID: 24058079
[TBL] [Abstract][Full Text] [Related]
2. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
Aral M; Mullen M
Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
[TBL] [Abstract][Full Text] [Related]
3. Results of percutaneous closure of patent foramen ovale with the GORE(®) septal occluder.
Knerr M; Bertog S; Vaskelyte L; Hofmann I; Sievert H
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1144-51. PubMed ID: 24323667
[TBL] [Abstract][Full Text] [Related]
4. The first clinical experience with the new GORE® septal occluder (GSO).
Søndergaard L; Loh PH; Franzen O; Ihlemann N; Vejlstrup N
EuroIntervention; 2013 Dec; 9(8):959-63. PubMed ID: 23764807
[TBL] [Abstract][Full Text] [Related]
5. Clinical Performance of the New Gore Septal Occluder in Patent Foramen Ovale Closure: A Single-Center Experience.
Sganzerla P; Rondi M; Pavone A; Aiolfi E; Facchinetti A; Funaro A; Negrini P
J Invasive Cardiol; 2015 Sep; 27(9):430-4. PubMed ID: 26332878
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.
Aytemir K; Oto A; Özkutlu S; Canpolat U; Kaya EB; Yorgun H; Şahiner L; Sunman H; Ateş AH; Kabakçı G
Congenit Heart Dis; 2013; 8(5):418-27. PubMed ID: 23601507
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous atrial shunt closure using the novel Occlutech Figulla device: 6-month efficacy and safety.
Van Den Branden BJ; Post MC; Plokker HW; Ten Berg JM; Suttorp MJ
J Interv Cardiol; 2011 Jun; 24(3):264-70. PubMed ID: 21198853
[TBL] [Abstract][Full Text] [Related]
8. Single centre experience with GORE-HELEX septal occluder for closure of PFO.
Ponnuthurai FA; van Gaal WJ; Burchell A; Mitchell A; Wilson N; Ormerod O
Heart Lung Circ; 2009 Apr; 18(2):140-2. PubMed ID: 18294910
[TBL] [Abstract][Full Text] [Related]
9. Intracardiac echocardiography during atrial septal defect and patent foramen ovale device closure in pediatric and adolescent patients.
Medford BA; Taggart NW; Cabalka AK; Cetta F; Reeder GS; Hagler DJ; Johnson JN
J Am Soc Echocardiogr; 2014 Sep; 27(9):984-90. PubMed ID: 24998516
[TBL] [Abstract][Full Text] [Related]
10. Using the GORE® Septal Occluder (GSO) in challenging patent foramen ovale (PFO) anatomies.
Geis NA; Pleger ST; Katus HA; Hardt SE
J Interv Cardiol; 2015 Apr; 28(2):190-7. PubMed ID: 25728716
[TBL] [Abstract][Full Text] [Related]
11. Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack.
Steinberg DH; Bertog SC; Momberger J; Franke J; Hofmann I; Renkhoff K; Joy S; Vaskelyte L; Sievert H
Catheter Cardiovasc Interv; 2015 Jun; 85(7):1262-7. PubMed ID: 24948394
[TBL] [Abstract][Full Text] [Related]
12. [Percutaneous closure of interatrial septal defects: mid-term follow-up results].
Oto MA; Aytemir K; Ozkutlu S; Kaya EB; Kabakcı G; Ateş AH; Yorgun H; Canpolat U
Turk Kardiyol Dern Ars; 2011 Jul; 39(5):385-95. PubMed ID: 21743262
[TBL] [Abstract][Full Text] [Related]
13. Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale.
Thompson AJ; Hagler DJ; Taggart NW
Catheter Cardiovasc Interv; 2015 May; 85(6):1053-7. PubMed ID: 25380406
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter PFO closure with GORE(®) septal occluder: early and mid-term clinical results.
Butera G; Saracino A; Danna P; Sganzerla P; Chessa M; Carminati M
Catheter Cardiovasc Interv; 2013 Nov; 82(6):944-9. PubMed ID: 23897659
[TBL] [Abstract][Full Text] [Related]
15. Initial use of the new GORE(®) septal occluder in patent foramen ovale closure: implantation and preliminary results.
MacDonald ST; Daniels MJ; Ormerod OJ
Catheter Cardiovasc Interv; 2013 Mar; 81(4):660-5. PubMed ID: 23436483
[TBL] [Abstract][Full Text] [Related]
16. Patent foramen ovale closure with the Gore septal occluder: initial UK experience.
Thomson JD; Hildick-Smith D; Clift P; Morgan G; Daniels M; Henderson R; Spence MS; Mahadevan VS; Crossland D; Ormerod O
Catheter Cardiovasc Interv; 2014 Feb; 83(3):467-73. PubMed ID: 23766247
[TBL] [Abstract][Full Text] [Related]
17. Closure of patent foramen ovale defects using GORE® CARDIOFORM septal occluder: Results from a prospective European multicenter study.
Hardt SE; Eicken A; Berger F; Schubert S; Carminati M; Butera G; Grohmann J; Höhn R; Nielsen-Kudsk JE; Hildick-Smith D; Settergren M; Thomson JD; Geis N; Søndergaard L
Catheter Cardiovasc Interv; 2017 Nov; 90(5):824-829. PubMed ID: 28296023
[TBL] [Abstract][Full Text] [Related]
18. Initial clinical experience with the Coherex FlatStent™ and FlatStent™ EF PFO closure system for in-tunnel PFO closure: results of the Coherex-EU study.
Sievert H; Wunderlich N; Reiffenstein I; Ruygrok P; Grube E; Buellesfeld L; Meier B; Schofer J; Muller D; Jones RK; Gillam L
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1135-43. PubMed ID: 22815250
[TBL] [Abstract][Full Text] [Related]
19. Application of Transesophageal Echocardiography in Amplatzer Atrial Septal Defect Occluder for Percutaneous Closure of Large Patent Foramen Ovale.
Du Y; Xie H; Shao H; Cheng G; He L; Wang X; He X; Lan B; Zhang Y; Tian G
Cardiovasc Ther; 2022; 2022():3226080. PubMed ID: 35936794
[TBL] [Abstract][Full Text] [Related]
20. Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies.
Abaci A; Unlu S; Alsancak Y; Kaya U; Sezenoz B
Catheter Cardiovasc Interv; 2013 Dec; 82(7):1123-38. PubMed ID: 23412921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
